Announcements Trials
Browse Landscape

Status

No longer available 1Approved for marketing 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 363Observational 39Expanded_access 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 15Neuroblastoma 13Glioma 11Pheochromocytoma 7Neoplasms 6Recurrence 5Paraganglioma 5Pancreatic Neoplasms 3Melanoma 3Head and Neck Neoplasms 3Brain Neoplasms 3Stomach Neoplasms 2Ovarian Neoplasms 2Oligodendroglioma 2Neurofibroma, Plexiform 2Neuroectodermal Tumors, Primitive 2Medulloblastoma 2Diffuse Intrinsic Pontine Glioma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Astrocytoma 2Wilms Tumor 1Urinary Bladder Neoplasms 1Typical Teratoid Rhabdoid Tumor 1Thyroid cancer, medullary 1Thyroid Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1

Interventions

vorasidenib 1paclitaxel-Angiopep-2 conjugate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Expanded_access × Oligodendroglioma × CNS × Clear all
NCT05592743 2024-11-05

Vorasidenib Expanded Access Program

Servier

Approved for marketing
CNS

Astrocytoma, Glioma, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Oligodendroglioma, Pathologic Processes, Recurrence, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Disease Attributes

NCT02755987 2016-06-07

Expanded Access to ANG1005 for Individual Patients

Angiochem Inc

No longer available
CNS

Astrocytoma, Oligodendroglioma, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡